Skip to main content
Main navigation
About us
Our work
Rationale
IDDO Team
Contact us
Our partners
Governance
IDDO Board
Data Access Committees
Data sharing
Contributing data
Accessing data
IDDO data sharing registrations
Research themes
COVID-19
Ebola
Malaria
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Chagas Disease
Febrile illness
Scrub typhus
Other diseases
Research
Malaria Tracking Resistance
Malaria Clinical Trials Toolkit
COVID-19 LSR Tool
VL Tool
Medicine Quality Monitoring Globe
Medicine Quality Scientific Literature Surveyor
Febrile Illness Surveyor
Publications
Tools & resources
News
User account menu
Log in
Register
Contact
Bandwidth
High
Low
Language switcher
English
Français
Español
Toggle navigation
About us
AMR networks
Research
Publications
Tools & resources
News
Search
Search
Search
News
i
Photo credit: Erly Tatontos, World Bank
News Article
26 Feb 2021
Applications for RSTMH 2021 grants open
i
Credit: Cristhian Alama Red Mundial
News Article
16 Oct 2019
PhD candidates urged to apply for scholarship
i
BMC Medicine
News Article
03 Apr 2019
Research highlight: New guidelines for reporting microbiology data
i
The economic costs of antimicrobial resistance (AMR) are higher than the sales price of most popular antibiotics, according to a recent MORU/IDDO study. Curbing the unnecessary use of antibiotics is key to dealing with the AMR issue head on, particularly in SE Asia, which has the highest rates of AMR and a big, informal medicine dispensing sector that aggravates the AMR problem. ©2018 MORU/Wellcome.
News Article
22 Aug 2018
Study details high hidden economic costs of antibiotic consumption
Pagination
Current page
1
Page
2
Next page
Next ›
Last page
Last »